ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 41008650

Interaction Between Heparan Sulfate Oligosaccharide and the Receptor-Binding Domain of the Wild-Type and Omicron Variant of the SARS-CoV-2 Spike Protein.

Mandalari M and 6 others. Biomolecules, 2025. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Interaction Between Heparan Sulfate Oligosaccharide and the Receptor-Binding Domain of the Wild-Type and Omicron Variant of the SARS-CoV-2 Spike Protein. Papers, record 41008650. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41008650

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interaction Between Heparan Sulfate Oligosaccharide and the Receptor-Binding Domain of the Wild-Type and Omicron Variant of the SARS-CoV-2 Spike Protein.
PubMed
Journal
Biomolecules
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-03-29
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mandalari MMarcohttps://orcid.org/0000-0002-8968-4896
2Parafioriti MMichelahttps://orcid.org/0000-0002-5538-5978
3Ni MMinghonghttps://orcid.org/0000-0001-6118-3750
4Benevelli FFrancesca
5Civera MMonicahttps://orcid.org/0000-0001-5171-1062
6Elli SStefanohttps://orcid.org/0000-0003-0686-2480
7Guerrini MMarcohttps://orcid.org/0000-0001-7246-9113

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Spike Glycoprotein, CoronavirusMajor topic
SARS-CoV-2Major topic
OligosaccharidesMajor topic
Heparan SulfateMajor topic
Humans
Molecular Dynamics Simulation
Protein Binding
Protein Domains
Binding Sites
Angiotensin-Converting Enzyme 2
COVID-19

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123,707,399Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles.Virus Res2013https://conductscience.org/library/papers/23707399PubMed
238,864,493Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern.Elife2024https://conductscience.org/library/papers/38864493PubMed
335,926,454Spike-heparan sulfate interactions in SARS-CoV-2 infection.Curr Opin Struct Biol2022https://conductscience.org/library/papers/35926454PubMed
433,368,089Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin.Thromb Haemost2020https://conductscience.org/library/papers/33368089PubMed
523,042,481Heparan sulfate biosynthesis: regulation and variability.J Histochem Cytochem2012https://conductscience.org/library/papers/23042481PubMed
624,914,125Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24914125PubMed
734,626,410Role of HSPGs in Systemic Bacterial Infections.Methods Mol Biol2022https://conductscience.org/library/papers/34626410PubMed
82,549,857The heparin-binding (fibroblast) growth factor family of proteins.Annu Rev Biochem1989https://conductscience.org/library/papers/2549857PubMed
939,401,361The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/39401361PubMed
1026,658,574Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures.PLoS Pathog2015https://conductscience.org/library/papers/26658574PubMed

1 to 10 of 40

See all 40 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ACE259,272PubTator's text mininghttps://conductscience.org/library/genes/59272

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41008650

GET https://conductscience.org/api/papers/v1/41008650/references?page=2

API referenceFor AI assistants